Anand Mehra is Director at Spark Therapeutics, Inc. (ONCE). They have made 41 open-market trades across 6 companies since 2013, most recently 2026-06-05.
7 open-market purchases totalling $32.6M since 2013, against 34 sales. Across 7 scored buys the stock is down 21.0% at ninety days, and 18.3 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -18.9% | -14.5% | -21.0% |
| Alpha | -15.7% | -13.2% | -18.3% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACRS | BUY | 2024-11-19 | 2024-11-20 | $2.25 | $3.0M | -9.5% | -36.0% | -45.9% |
| ACRS | BUY | 2018-10-22 | 2018-10-23 | $10.75 | $8.0M | -1.8% | -31.6% | -50.6% |
| PRNB | BUY | 2018-09-18 | 2018-09-20 | $17.00 | $4.6M | -6.7% | -17.9% | -8.5% |
| ONCE | SELL | 2017-07-24 | 2017-07-26 | $70.14 | $14.8M | +6.3% | +8.6% | +15.5% |
| ONCE | SELL | 2017-07-24 | 2017-07-26 | $70.15 | $14.9M | +6.3% | +8.6% | +15.5% |
| ONCE | SELL | 2017-06-20 | 2017-06-22 | $65.00 | $410K | +5.2% | +18.8% | +41.2% |
| ONCE | SELL | 2017-03-02 | 2017-03-06 | $65.01 | $2.0M | -2.6% | -14.6% | -13.4% |
| ONCE | SELL | 2017-02-27 | 2017-03-01 | $65.02 | $11.0M | -9.7% | -17.0% | -20.3% |
| ONCE | SELL | 2017-02-17 | 2017-02-22 | $65.01 | $980K | -1.5% | -14.1% | -10.5% |
| ONCE | SELL | 2017-02-16 | 2017-02-16 | $65.01 | $189K | +0.5% | -9.4% | -15.7% |
| ONCE | SELL | 2017-02-15 | 2017-02-16 | $65.03 | $2.0M | +0.5% | -9.4% | -15.7% |
| ONCE | SELL | 2017-02-14 | 2017-02-16 | $65.02 | $62K | +0.5% | -9.4% | -15.7% |
| ONCE | SELL | 2017-02-14 | 2017-02-16 | $65.03 | $2.3M | +0.5% | -9.4% | -15.7% |
| ONCE | SELL | 2017-02-09 | 2017-02-13 | $65.06 | $4.9M | -5.4% | -6.1% | -10.4% |
| ONCE | SELL | 2017-02-07 | 2017-02-07 | $65.04 | $130K | +2.3% | -9.8% | -8.0% |
| ONCE | SELL | 2017-02-03 | 2017-02-07 | $65.06 | $1.6M | +2.3% | -9.8% | -8.0% |
| ONCE | SELL | 2017-02-03 | 2017-02-07 | $65.06 | $1.5M | +2.3% | -9.8% | -8.0% |
| ACRS | SELL | 2017-01-10 | 2017-01-12 | $28.25 | $21.2M | -5.0% | -4.9% | +10.5% |
| ONCE | SELL | 2016-12-16 | 2016-12-19 | $53.26 | $12.2M | -4.1% | +7.9% | +11.5% |
| ONCE | SELL | 2016-12-15 | 2016-12-19 | $53.46 | $18.7M | -4.1% | +7.9% | +11.5% |
| ONCE | SELL | 2016-12-15 | 2016-12-19 | $53.07 | $3.7M | -4.1% | +7.9% | +11.5% |
| ONCE | SELL | 2016-12-13 | 2016-12-13 | $53.32 | $1.2M | -0.6% | +10.2% | +11.7% |
| ONCE | SELL | 2016-12-09 | 2016-12-13 | $55.17 | $6.8M | -0.6% | +10.2% | +11.7% |
| ONCE | SELL | 2016-12-09 | 2016-12-13 | $55.72 | $4.5M | -0.6% | +10.2% | +11.7% |
| MRNS | SELL | 2016-10-20 | 2016-10-24 | $1.39 | $1.0M | -20.5% | -12.1% | +3.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total | $194.7M |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close.